Technical Analysis for MBIO - Mustang Bio, Inc.

Grade Last Price % Change Price Change
grade D 3.76 -0.53% -0.02
MBIO closed down 0.53 percent on Friday, February 14, 2020, on 42 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical MBIO trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 50 DMA Bearish -0.53%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.53%
Inside Day Range Contraction -0.53%
50 DMA Support Bullish -1.31%
Outside Day Range Expansion -1.31%
MACD Bearish Centerline Cross Bearish -1.31%
50 DMA Support Bullish -1.31%
Inside Day Range Contraction -1.31%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Mustang Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to utilize the power of the patient’s own immune system to eliminate cancer cells. It seeks to acquire rights to technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market. The Company is developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells (CAR -T) technology, which uses the patient’s own T cells to engage and destroy specific tumors. The Company, through its agreement with City of Hope National Medical Center, is using three novel CAR T therapies in the development of cancer treatments, including human epidermal growth factor receptor 2 CAR T technology, CS1-specific CAR T technology, and prostate stem cell antigen CAR T technology.
Medicine Biopharmaceutical Cancer Immunotherapy Immune System Cancer Treatments Gene Therapy Virotherapy Cancer Immunotherapy Kite Pharma Chimeric Antigen Receptor Cancer Immunotherapy Products T Cell Cellectis

Is MBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 10.2
52 Week Low 2.51
Average Volume 340,989
200-Day Moving Average 3.52
50-Day Moving Average 3.80
20-Day Moving Average 3.91
10-Day Moving Average 3.81
Average True Range 0.19
ADX 13.35
+DI 18.81
-DI 21.71
Chandelier Exit (Long, 3 ATRs ) 4.04
Chandelier Exit (Short, 3 ATRs ) 4.18
Upper Bollinger Band 4.27
Lower Bollinger Band 3.56
Percent B (%b) 0.28
BandWidth 18.00
MACD Line -0.02
MACD Signal Line 0.01
MACD Histogram -0.0304
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.94
Resistance 3 (R3) 3.94 3.88 3.91
Resistance 2 (R2) 3.88 3.83 3.88 3.90
Resistance 1 (R1) 3.82 3.81 3.79 3.82 3.89
Pivot Point 3.76 3.76 3.75 3.76 3.76
Support 1 (S1) 3.70 3.71 3.67 3.70 3.63
Support 2 (S2) 3.64 3.69 3.64 3.62
Support 3 (S3) 3.58 3.64 3.61
Support 4 (S4) 3.58